Lilly shareholders to vote again on splitting CEO, board chair roles
For the third year in a row, an investor is proposing that the pharmaceutical company scrap the tradition of combining the role of chief executive officer and board chair.
For the third year in a row, an investor is proposing that the pharmaceutical company scrap the tradition of combining the role of chief executive officer and board chair.
Indianapolis-based health insurer Anthem Inc. is suing a former executive, claiming he stole trade secrets, went to work for a direct competitor, and breached a contract involving restricted stock agreements.
The Indianapolis-based health insurer said the name change will better reflect its mission of “elevating whole health and advancing health beyond healthcare.”
A leading critic of IU Health said the huge contribution appears to be a way to make the hospital system’s profits drop below $1 billion last year as it faces higher scrutiny from the Indiana General Assembly and other groups for its high fees and large profits.
The medical-device maker is vigorously defending itself against a mountain of lawsuits that claim its inferior vena cava (IVC) filters, designed to catch blood clots, are unsafe.
The health system said the funding plan will “support community health initiatives and education and workforce development programs statewide, including neighborhoods around its downtown Indianapolis campus.”
The parent of electric utility AES Indiana announced Friday morning it plans to give up coal as a fuel source, a move likely to lead to the early shutdown of coal-fired units at its massive Petersburg Generating Station.
Elanco Animal Health Inc. said Thursday morning that revenue climbed 46% last year and its net loss narrowed, strengthening its financial position as it prepares to break ground this spring on a new $100 million headquarters in Indianapolis.
The Indiana General Assembly has overwhelmingly passed a bill that would allow electric utilities to build small modular reactors, a move that could pave the way for commercial nuclear power in the state for the first time.
A U.S. Navy team that was dispatched to Methodist Hospital in Indianapolis to help relieve overwhelmed staffers during a surge in COVID-19 cases has wrapped up its deployment after 60 days.
The fines are one way Medicare is clamping down on hospitals, using penalties and incentives authorized by the Affordable Care Act to push for better outcomes, fewer safety problems and a lower number of readmissions.
The U.S. Department of Justice said it obtained $5 billion in settlements and judgments last year from drug and medical device manufacturers, managed care providers, hospitals, pharmacies, hospice organizations, laboratories and physicians.
The Indianapolis-based drugmaker said the antibody is effective against the omicron variant and it has already manufactured several hundred thousand doses. The deal calls for the federal government to pay Lilly more than $720 million.
The FDA has agreed to speed up review of donanemab, but the Centers for Medicare and Medicaid Services is moving to limit reimbursement for drugs in this class to only patients in clinical trials.
The deal calls for the federal government to pay Eli Lilly and Co. more than $720 million for the antibody, which the company said is effective against all COVID-19 variants.
Novus Capital Corp. II announced in September it would merge with Energy Vault in a deal that would take the 4-year-old company public. The transaction gives Energy Vault an immediate cash infusion of $355 million.
The Eagle Valley power plant in Martinsville is one of three generating stations that provides electricity for about 500,000 AES Indiana customers in central Indiana.
The maker of agricultural seeds, insecticides and herbicides had been based in Wilmington, Delaware, since its spinoff from parent DowDuPont in 2019.
The reproductive health unit includes products for obstetrics and gynecology, in vitro fertilization and assisted reproductive technology.
It’s the latest twist in a long-running story involving Dr. Timothy Story, who worked for St. Vincent Medical Group for a decade, but was fired in August 2020 after St. Vincent learned of a federal investigation into his prescribing practices.